Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1968 1
1969 1
1970 1
1973 1
1975 2
1977 1
1979 4
1980 4
1981 2
1985 1
1988 1
1990 1
1992 2
1993 3
1994 1
1996 7
1997 3
1998 2
1999 3
2000 5
2001 7
2002 15
2003 10
2004 11
2005 13
2006 17
2007 20
2008 22
2009 31
2010 20
2011 29
2012 28
2013 29
2014 36
2015 41
2016 44
2017 32
2018 35
2019 17
2020 10
2021 12
2022 2
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

458 results

Results by year

Filters applied: . Clear all
Page 1
A new equation to estimate glomerular filtration rate.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). Levey AS, et al. Among authors: kusek jw. Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006. Ann Intern Med. 2009. PMID: 19414839 Free PMC article.
Estimating glomerular filtration rate from serum creatinine and cystatin C.
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators. Inker LA, et al. Among authors: kusek jw. N Engl J Med. 2012 Jul 5;367(1):20-9. doi: 10.1056/NEJMoa1114248. N Engl J Med. 2012. PMID: 22762315 Free PMC article.
Arteriovenous Fistula Maturation, Functional Patency, and Intervention Rates.
Huber TS, Berceli SA, Scali ST, Neal D, Anderson EM, Allon M, Cheung AK, Dember LM, Himmelfarb J, Roy-Chaudhury P, Vazquez MA, Alpers CE, Robbin ML, Imrey PB, Beck GJ, Farber AM, Kaufman JS, Kraiss LW, Vongpatanasin W, Kusek JW, Feldman HI. Huber TS, et al. Among authors: kusek jw. JAMA Surg. 2021 Dec 1;156(12):1111-1118. doi: 10.1001/jamasurg.2021.4527. JAMA Surg. 2021. PMID: 34550312 Free PMC article.
Prevalence of chronic kidney disease in the United States.
Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS. Coresh J, et al. Among authors: kusek jw. JAMA. 2007 Nov 7;298(17):2038-47. doi: 10.1001/jama.298.17.2038. JAMA. 2007. PMID: 17986697
Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Anderson AH, Xie D, Wang X, Baudier RL, Orlandi P, Appel LJ, Dember LM, He J, Kusek JW, Lash JP, Navaneethan SD, Ojo A, Rahman M, Roy J, Scialla JJ, Sondheimer JH, Steigerwalt SP, Wilson FP, Wolf M, Feldman HI; CRIC Study Investigators. Anderson AH, et al. Among authors: kusek jw. Am J Kidney Dis. 2021 Jan;77(1):56-73.e1. doi: 10.1053/j.ajkd.2020.07.011. Epub 2020 Aug 28. Am J Kidney Dis. 2021. PMID: 32866540 Free PMC article. Clinical Trial.
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.
McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. McConnell JD, et al. Among authors: kusek jw. N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656. N Engl J Med. 2003. PMID: 14681504 Free article. Clinical Trial.
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
Heerspink HJL, Inker LA, Tighiouart H, Collier WH, Haaland B, Luo J, Appel GB, Chan TM, Estacio RO, Fervenza F, Floege J, Imai E, Jafar TH, Lewis JB, Kam-Tao Li P, Locatelli F, Maes BD, Perna A, Perrone RD, Praga M, Schena FP, Wanner C, Xie D, Greene T; on behalf of CKD-EPI CT. Heerspink HJL, et al. J Am Soc Nephrol. 2023 Jun 1;34(6):955-968. doi: 10.1681/ASN.0000000000000117. Epub 2023 Mar 15. J Am Soc Nephrol. 2023. PMID: 36918388 Clinical Trial.
458 results